for primary treatment of hd , the german hodgkin study group added a third non-cross-resistant regimen , imep ( ifosfamide , methotrexate , etoposide , prednisone ) , to supplement copp ( cyclophosphamide , vincristine , procarbazine , prednisone ) and abv in the primary treatment of hd .
C0010583
cyclophosphamide
C0019829
hd